Clinical Trials Browser

Phase 1/2 × Withdrawn × Head and Neck Neoplasms × Clear all

NCT05879484 2025-07-10

Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS

Phase 1/2 Withdrawn

Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lung Neoplasms

NCT02143622 2016-04-21

Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma Patients

Phase 1/2 Withdrawn

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01506427 2012-12-17

A Study of [F-18]HX4 (PET Imaging)Evaluated in Head and Neck Cancer Patients

Phase 1/2 Withdrawn

Head and Neck Neoplasms

NCT00540332 2009-03-02

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy

Phase 1/2 Withdrawn

Head and Neck Neoplasms, Neoplasms, Stomatitis